In infection models and autoimmune disease models, EZH2 inhibits the expression of genes and signaling pathways involved in anti-inflammatory function, such as PPARγ, SOCS1, STAT6, etc. (35, 36). This evidence concerns the gene PPARG and autoimmune disease.